The following article by Phil Kerpen is sponsored by American Commitment.
Last year, the catastrophically false Inflation Reduction Act (IRA) was about 270 billion from Medicare prescription drug spending to fund green energy and electric vehicle giveaways and other democratic special benefits priorities. It was a punch bag on a campaign trail to raid the dollar. What is less well known is that the bill included raids on small molecule drugs, subject to price control four years ago than biotech drugs. It is called a “pill penalty” because it diverts research funds from tablets to injections.
The IRA optionally sets various criteria for “small molecule” drugs that come in the form of pills, capsules, and tablets. Drugs in tablet form can be subject to government price control nine years after FDA approval, but “large molecule” drugs that come injected or intravenously are permitted to set market prices for 13 years.
You don't have to be an economist or a leading business expert to predict inevitable outcomes. With little investment in cutting-edge small molecule drugs as research and development dollars, we will move on to allowed biotech drugs on long runways to gain a return on investment. Previous government price management outlook has a major impact as it could cost over $1 billion to develop and bring new drugs to the market.
Patients suffer because they target some of the most widely used, game-changing, effective drugs they receive. Drugs in tablet form are used to treat a variety of serious medical conditions, including cancer, diabetes, and cardiovascular disease.
Professor at the University of Chicago Estimated The pill penalty cuts R&D investments by more than $230 billion, resulting in the loss of 79 new drugs. “This forgotten innovation is expected to lose 101.6 million lives as it missed opportunities to improve health,” they conclude. They also note that their estimates may be too conservative.
Savings from government cut drug spending do not even reinforce older people or Medicare. They go to health insurance companies in the form of electric car makers, super-large Obamacare subsidies and other democratic interest groups.
The entire Inflation Reduction Act needs to be abolished, but at an absolute minimum, Congress needs to ensure that Rep. Greg Murphy (R-NC) have a route to innovative treatments (R-NC)amazing) Actions to eliminate pill penalties in future settlement packages. Murphy's two-page bill extends the same protection from price control for molecular drugs, large and small.
The new study shows overwhelming support for ending the pill penalty among older adults. My organization's commitment to senior projects I recently voted Voters over the age of 55, with a high probability of 1,600, are seeking opinions on a variety of issues, including pill penalties. It turns out that 86% are concerned about the effects of pil penalties on pharmacy R&D investments, availability of small molecule drugs, and the decline in new tablets and tablet-forming drugs that could help patients combat chronic diseases I did.
Additionally, over 75% of survey respondents agreed to correct the pill penalty by granting small molecule drugs the same price control exemption as biology, with over 80% doing grandly to achieve it. It shows that it supports the
The complete repeal of the Inflation Reduction Act must be a legislative goal, but if it cannot order enough votes to pass, ending the Pill Penalty via the Epic Act will result in a settlement It's an absolute simple thing to include.
Phil Carpen is the president of American Commitment.
